$1.24
-0.05-3.88%
Comments
Loading...
Moleculin Biotech Stock Guidance | NASDAQ:MBRX | Benzinga
Moleculin Biotech issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
Data brought to you by Benzinga APIs
FAQ
What is the most recent guidance for Moleculin Biotech (MBRX)?
There have been no specific sales or earnings guidance reported for Moleculin Biotech in recent months.
Browse guidance and forecast on all stocks.